Scilex Holding Co Files 8-K/A Amendment

TL;DR

Scilex Holding Co filed an 8-K/A amendment, changing their accountant.

AI Summary

Scilex Holding Company filed an amendment (8-K/A) on November 22, 2024, to a previous filing. This amendment pertains to changes in the registrant's certifying accountant and includes financial statements and exhibits. The earliest event reported in this amendment was on November 19, 2024.

Why It Matters

This filing indicates a change in Scilex Holding Co's certifying accountant, which could impact financial reporting and investor confidence.

Risk Assessment

Risk Level: medium — Changes in certifying accountants can sometimes signal underlying issues with financial reporting or internal controls.

Key Players & Entities

• Scilex Holding Company (company) — Registrant
• 0001193125-24-263737 (filing_id) — Accession Number
• November 19, 2024 (date) — Earliest event reported
• November 22, 2024 (date) — Date of report

FAQ

Key Financial Figures

• $0.0001 — ich registered Common stock, par value $0.0001 per share SCLX The Nasdaq Stock Mar
• $11.50 — mon stock, each at an exercise price of $11.50 per share SCLXW The Nasdaq Stock Ma

Filing Documents

• d888761d8ka.htm (8-K/A) — 44KB
• d888761dex161.htm (EX-16.1) — 21KB
• g888761dsp7.jpg (GRAPHIC) — 7KB
• g888761dsp9.jpg (GRAPHIC) — 7KB
• 0001193125-24-263737.txt ( ) — 260KB
• sclxw-20241119.xsd (EX-101.SCH) — 4KB
• sclxw-20241119_def.xml (EX-101.DEF) — 14KB
• sclxw-20241119_lab.xml (EX-101.LAB) — 23KB
• sclxw-20241119_pre.xml (EX-101.PRE) — 15KB
• d888761d8ka_htm.xml (XML) — 7KB

Forward-Looking Statements

Forward-Looking Statements 4 anticipated engagement of a new independent registered public accounting firm constitute forward looking statements. Such forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks related to the Company's ability to file the Q3 Form 10-Q, the Company's ability to regain compliance with the Nasdaq continued listing standards and to maintain the listing of the Company's securities thereon, the risk that the investigation referenced herein will take longer than anticipated, the outcome of such investigation, the potential for the outcome of the investigation to materially impact the Q2 Form 10-Q and/or the Q3 Financials, the Company's ability to expeditiously engage a new audit firm, the Company's ability to perform its obligations that would be triggered by an event of default under the Existing Notes, the Company's ability to continue to comply with applicable covenants under the Existing Notes, and the risk of litigation or other actions arising from the investigation and its findings or the failure to timely file the Q3 Form 10-Q or any subsequent SEC filing. Additional risks and uncertainties faced by the Company are contained from time to time in the Company's filings with the SEC, including, but not limited to, the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC on March 12, 2024, and its quarterly reports on Form 10-Q and current reports on Form 8-K, which you may obtain for free on the SEC's website at www.sec.gov. Collectively, these risks and uncertainties could cause the Co

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 16.1 Letter from Ernst & Young LLP dated November 20, 2024 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). 5

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCILEX HOLDING COMPANY By: /s/ Jaisim Shah Name: Jaisim Shah Title: Chief Executive Officer & President Date: November 22, 2024 6

View Full Filing

View this 8-K/A filing on SEC EDGAR